Taxotere Promotional Efforts Will Focus On Metastatic Breast Cancer

Taxotere promotional efforts regarding metastatic breast cancer use will be a "major field of activity during the months to come in the U.S.," Sanofi-Aventis Exec VP-Pharmaceutical Operations Hanspeter Spek said